Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Operating Margin (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Operating Margin for 16 consecutive years, with 10.02% as the latest value for Q4 2025.

  • Quarterly Operating Margin rose 763.0% to 10.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.27% through Dec 2025, up 1072.0% year-over-year, with the annual reading at 6.27% for FY2025, 1072.0% up from the prior year.
  • Operating Margin hit 10.02% in Q4 2025 for Cumberland Pharmaceuticals, up from 23.7% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 11.03% in Q1 2025 to a low of 66.07% in Q4 2023.
  • Historically, Operating Margin has averaged 17.34% across 5 years, with a median of 17.13% in 2023.
  • Biggest five-year swings in Operating Margin: plummeted -4110bps in 2023 and later soared 4841bps in 2024.
  • Year by year, Operating Margin stood at 52.33% in 2021, then surged by 52bps to 24.97% in 2022, then tumbled by -165bps to 66.07% in 2023, then soared by 73bps to 17.65% in 2024, then soared by 43bps to 10.02% in 2025.
  • Business Quant data shows Operating Margin for CPIX at 10.02% in Q4 2025, 23.7% in Q3 2025, and 6.9% in Q2 2025.